NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) molecules are expressed on the cell surface, where they present peptides to T cells, which gives them a key role in the development of T-cell immune responses. MHC molecules come in two main variants: MHC Class I (MHC-I) and MHC Class II (MHC-II). MHC-I predominantly present peptides derived from intracellular proteins, whereas MHC-II predominantly presents peptides from extracellular proteins. In both cases, the binding between MHC and antigenic peptides is the most selective step in the antigen presentation pathway. Therefore, the prediction of peptide binding to MHC is a powerful utility to predict the possible specificity of a T-cell immune response. Commonly MHC binding prediction tools are trained on binding affinity or mass spectrometry-eluted ligands. Recent studies have however demonstrated how the integration of both data types can boost predictive performances. Inspired by this, we here present NetMHCpan-4.1 and NetMHCIIpan-4.0, two web servers created to predict binding between peptides and MHC-I and MHC-II, respectively. Both methods exploit tailored machine learning strategies to integrate different training data types, resulting in state-of-the-art performance and outperforming their competitors. The servers are available at http://www.cbs.dtu.dk/services/NetMHCpan-4.1/ and http://www.cbs.dtu.dk/services/NetMHCIIpan-4.0/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these tools, NetMHCpan stands out in predicting the binding affinity between peptides and MHC-I/II, respectively [139].”
From Single-cell sequencing to multi-omics: technologies and applications (2024) · cites this paper as [139]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jurtz, V., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700893 · Cited by 1,470
Self-citationImproved methods for predicting peptide binding affinity to MHC class II molecules
Jensen, K. K., Andreatta, M., Marcatili, P., Buus, S., Greenbaum, J. A., Yan, Z., Sette, A., Peters, B., & Nielsen, M. (2018) · Immunology · doi:10.1111/imm.12889 · Cited by 794
Self-citationAbelin, J. G., Keskin, D. B., Sarkizova, S., Hartigan, C. R., Zhang, W., Sidney, J., Stevens, J., Lane, W., Zhang, G. L., Eisenhaure, T. M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.007 · Cited by 617
Nielsen, M., & Andreatta, M. (2016) · Genome Medicine · doi:10.1186/s13073-016-0288-x · Cited by 517
Self-citationSarkizova, S., Klaeger, S., Le, P. M., Li, L. W., Oliveira, G., Keshishian, H., Hartigan, C. R., Zhang, W., Braun, D. A., Ligon, K. L., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0322-9 · Cited by 499
Reynisson, B., Barra, C., Kaabinejadian, S., Hildebrand, W. H., Peters, B., & Nielsen, M. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00874 · Cited by 445
Self-citationMHCflurry: Open-Source Class I MHC Binding Affinity Prediction
O'Donnell, T. J., Rubinsteyn, A., Bonsack, M., Riemer, A. B., Laserson, U., & Hammerbacher, J. (2018) · Cell Systems · doi:10.1016/j.cels.2018.05.014 · Cited by 409
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
Bulik-Sullivan, B., Busby, J., Palmer, C. D., Davis, M. J., Murphy, T., Clark, A., Busby, M., Duke, F., Yang, A., Young, L., et al. (2019) · Nature Biotechnology · doi:10.1038/nbt.4313 · Cited by 307
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes
Racle, J., Michaux, J., Rockinger, G. A., Arnaud, M., Bobisse, S., Chong, C., Guillaume, P., Coukos, G., Harari, A., Jandus, C., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0289-6 · Cited by 289
Karosiene, E., Rasmussen, M., Blicher, T., Lund, O., Buus, S., & Nielsen, M. (2013) · Immunogenetics · doi:10.1007/s00251-013-0720-y · Cited by 272
Self-citation
Research works printed but not linked: 1
- O’Donnell T.J., Rubinsteyn A., Bonsack M., Riemer A.B., Laserson U., Hammerbacher J. 2020; MHCFlurry https://github.com/openvax/mhcflurry. 29960884
Cited by
Items 201–300 of 1,014
Wohlwend, J., Nathan, A., Shalon, N., Crain, C. R., Tano-Menka, R., Goldberg, B., Richards, E., Gaiha, G. D., & Barzilay, R. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-024-00971-y · Cited by 53
Current and prospective computational approaches and challenges for developing COVID-19 vaccines
Hwang, W., Lei, W., Katritsis, N. M., MacMahon, M., Chapman, K. L., & Han, N. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.004 · Cited by 52
Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
Okada, M., Shimizu, K., & Fujii, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052594 · Cited by 52
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures
Bakir, M. A., Reading, J. L., Gamble, S., Rosenthal, R., Uddin, I., Rowan, A., Przewrocka, J., Rogers, A., Wong, Y. N. S., Bentzen, A. K., et al. (2025) · Nature · doi:10.1038/s41586-025-08586-y · Cited by 52
Predicting MHC-I ligands across alleles and species: how far can we go?
Tadros, D. M., Racle, J., & Gfeller, D. (2025) · Genome Medicine · doi:10.1186/s13073-025-01450-8 · Cited by 52
Deepthi, V., Sasikumar, A., Mohanakumar, K. P., & Rajamma, U. (2025) · Scientific Reports · doi:10.1038/s41598-025-92956-z · Cited by 52
SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects
Zhao, J., Wang, L., Schank, M., Dang, X., Lu, Z., Cao, D., Khanal, S., Nguyen, L. N., Nguyen, L. N., Zhang, J., et al. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198508 · Cited by 51
T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations
Nersisyan, S. A., Zhiyanov, A., Shkurnikov, M. Y., & Tonevitsky, A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab701 · Cited by 51
TransLnc: a comprehensive resource for translatable lncRNAs extends immunopeptidome
Lv, D., Chang, Z., Cai, Y., Li, J., Wang, L., Jiang, Q., Xu, K., Ding, N., Li, X., Xu, J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab847 · Cited by 51
Bravi, B., Tubiana, J., Cocco, S., Monasson, R., Mora, T., & Walczak, A. M. (2021) · Cell Systems · doi:10.1016/j.cels.2020.11.005 · Cited by 50
DeepNeo: a webserver for predicting immunogenic neoantigens
Kim, J. Y., Bang, H., Noh, S.-J., & Choi, J. K. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad275 · Cited by 50
Li, F., Wang, C., Guo, X., Akutsu, T., Webb, G. I., Coin, L., Kurgan, L., & Song, J. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad372 · Cited by 50
Lin, V., Cheung, M., Gowthaman, R., Eisenberg, M., Baker, B. M., & Pierce, B. G. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae840 · Cited by 50
Artificial intelligence in cancer research: learning at different levels of data granularity
Cirillo, D., Núñez‐Carpintero, I., & Valencia, A. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12920 · Cited by 51
Infectious disease mRNA vaccines and a review on epitope prediction for vaccine design
Cai, X., Li, J. J., Liu, T., Brian, O., & Li, J. (2021) · Briefings in Functional Genomics · doi:10.1093/bfgp/elab027 · Cited by 50
Rcheulishvili, N., Mao, J., Papukashvili, D., Liu, C., Wang, Z., Zhao, J., Xie, F., Pan, X., Ji, Y., He, Y., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.12.066 · Cited by 49
Innate receptors with high specificity for HLA class I–peptide complexes
Sim, M. J. W., Brennan, P., Wahl, K. L., Lu, J., Rajagopalan, S., Sun, P. D., & Long, E. O. (2023) · Science Immunology · doi:10.1126/sciimmunol.adh1781 · Cited by 49
Sun, R., Qian, M. G., & Zhang, X. (2024) · mAbs · doi:10.1080/19420862.2024.2324836 · Cited by 49
Cieri, N., Maurer, K., & Wu, C. J. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0301 · Cited by 49
Wu, D., Kolesnikov, A. V., Yin, R. M., Guest, J. D., Gowthaman, R., Shmelev, A., Serdyuk, Y. V., Dianov, D. V., Efimov, G. A., Pierce, B. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27669-8 · Cited by 50
Takata, H., Kakazu, J. C., Mitchell, J. L., Kroon, E. D. M. B., Colby, D. J., Sacdalan, C., Bai, H., Ehrenberg, P. K., Geretz, A., Buranapraditkun, S., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104253 · Cited by 49
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
Mota, I. A., Patrucco, E., Mastini, C., Mahadevan, N. R., Thai, T. C., Bergaggio, E., Cheong, T.-C., Leonardi, G. C., Atabay, E. K., Campisi, M., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00591-2 · Cited by 49
Advances and challenges in neoantigen prediction for cancer immunotherapy
Zhang, Y., Chen, T., Li, X., Lan, A., Ji, P.-F., Zhu, Y., & Ma, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1617654 · Cited by 48
Bernal, E., Gimeno, L., Alcaraz, M. J., Quadeer, A. A., Moreno, M., Martínez‐Sánchez, M. V., Campillo, J. A., Gomez, J. M., Peláez, A., García, E., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab228 · Cited by 48
An immunoinformatics study: designing multivalent T-cell epitope vaccine against canine circovirus
Jain, P., Joshi, A., Akhtar, N., Krishnan, S., & Kaushik, V. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00220-4 · Cited by 47
The SysteMHC Atlas v2.0, an updated resource for mass spectrometry-based immunopeptidomics
Huang, X., Gan, Z., Cui, H., Lan, T., Liu, Y., Caron, É., & Shao, W. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1068 · Cited by 47
An immunogenetic basis for lung cancer risk
Krishna, C., Tervi, A. M., Saffern, M., Wilson, E. A., Yoo, S., Mars, N., Roudko, V., Cho, B. A., Jones, S. E., Vaninov, N., et al. (2024) · Science · doi:10.1126/science.adi3808 · Cited by 48
Abbasi, B. A., Saraf, D., Sharma, T., Sinha, R., Singh, S., Sood, S., Gupta, P., Gupta, A., Mishra, K., Kumari, P., et al. (2022) · PeerJ · doi:10.7717/peerj.13380 · Cited by 47
The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein
Knierman, M. D., Lannan, M. B., Spindler, L. J., McMillian, C. L., Konrad, R. J., & Siegel, R. W. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108454 · Cited by 46
Mahapatra, S. R., Dey, J., Kushwaha, G. S., Puhan, P., Mohakud, N. K., Panda, S. K., Lata, S., Misra, N., & Suar, M. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1964600 · Cited by 46
Ahmad, S., Nazarian, S., Alizadeh, A., Hajialilou, M. P., Tahmasebian, S., Alharbi, M., Alasmari, A. F., Shojaeian, A., Ghatrehsamani, M., Irfan, M., et al. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2258403 · Cited by 46
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease
Yogeshwar, S., Muñiz‐Castrillo, S., Sabater, L., Sempere, V. P., Mallajosyula, V. V. A., Luo, G., Yan, H., Yu, E., Zhang, J., Lin, L., et al. (2024) · Brain · doi:10.1093/brain/awae048 · Cited by 46
Immunoinformatics Approach for Epitope-Based Vaccine Design: Key Steps for Breast Cancer Vaccine
Prawiningrum, A. F., Paramita, R. I., & Panigoro, S. S. (2022) · Diagnostics · doi:10.3390/diagnostics12122981 · Cited by 45
Fisch, A., Reynisson, B., Benedictus, L., Nicastri, A., Vasoya, D., Morrison, I. W., Buus, S., Ferreira, B. R., Santos, I. K. F. D. M., Ternette, N., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001409 · Cited by 45
Self-citationPANDORA: A Fast, Anchor-Restrained Modelling Protocol for Peptide: MHC Complexes
Marzella, D. F., Parizi, F. M., Tilborg, D. V., Renaud, N., Sybrandi, D., Buzatu, R., Rademaker, D. T., ‘t Hoen, P. A. C., & Xue, L. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878762 · Cited by 44
Mohammadi, Y., Nezafat, N., Negahdaripour, M., Eskandari, S., & Zamani, M. (2022) · Immunologic Research · doi:10.1007/s12026-022-09351-3 · Cited by 44
CapsNet-MHC predicts peptide-MHC class I binding based on capsule neural networks
Kalemati, M., Darvishi, S., & Koohi, S. (2023) · Communications Biology · doi:10.1038/s42003-023-04867-2 · Cited by 44
Hall, M. S., Teer, J. K., Yu, X., Branthoover, H., Snedal, S. A., Rodríguez-Valentín, M., Nagle, L., Scott, E. N., Schachner, B. I., Innamarato, P., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007288 · Cited by 44
Carré, A., Samassa, F., Zhou, Z., Perez-Hernandez, J., Lekka, C., Manganaro, A., Oshima, M., Liao, H., Parker, R. S., Nicastri, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55908-9 · Cited by 44
Implications of Tumor–Immune Coevolution on Cancer Evasion and Optimized Immunotherapy
George, J. T., & Levine, H. (2021) · Trends in cancer · doi:10.1016/j.trecan.2020.12.005 · Cited by 44
MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange
Abualrous, E. T., Stolzenberg, S., Sticht, J., Wieczorek, M., Roske, Y., Günther, M., Dähn, S., Boesen, B. B., Calvo, M. M., Biese, C., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01316-3 · Cited by 43
Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): progress and challenges
Qiu, L., Chirman, D. M., Clark, J. R., Xing, Y., Santos, H. H., Vaughan, E. E., & Maresso, A. W. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2359691 · Cited by 43
Applications of Machine and Deep Learning in Adaptive Immunity
Pertseva, M., Gao, B., Neumeier, D., Yermanos, A., & Reddy, S. T. (2021) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-101420-125021 · Cited by 43
Ensemble Machine Learning Model to Predict SARS-CoV-2 T-Cell Epitopes as Potential Vaccine Targets
Bukhari, S. N. H., Jain, A., Haq, E., Mehbodniya, A., & Webber, J. L. (2021) · Diagnostics · doi:10.3390/diagnostics11111990 · Cited by 43
Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach
Campbell, K. M., Steiner, G., Wells, D. K., Ribas, A., & Kalbasi, A. (2020) · eScholarship (California Digital Library) · doi:10.1101/2020.03.30.016931 · Cited by 42
MHC II immunogenicity shapes the neoepitope landscape in human tumors
Kim, J. Y., Cha, H., Kim, K., Sung, C., An, J., Bang, H., Kim, H., Yang, J. O., Chang, S., Shin, I., et al. (2023) · Nature Genetics · doi:10.1038/s41588-022-01273-y · Cited by 42
Gomez‐Zepeda, D., Arnold-Schild, D., Beyrle, J., Declercq, A., Gabriels, R., Kumm, E. J., Preikschat, A., Łącki, M. K., Hirschler, A., Rijal, J. B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46380-y · Cited by 42
Targeting cancer with precision: strategical insights into TCR-engineered T cell therapies
Lin, P., Lin, Y., Mai, Z., Zheng, Y., Zheng, J., Zhou, Z., Zhao, X., & Cui, L. (2024) · Theranostics · doi:10.7150/thno.104594 · Cited by 42
Sun, Y., Gao, Y., Su, T., Zhang, L., Zhou, H., Zhang, J., Sun, H., Bai, J., & Jiang, P. (2025) · ACS Nano · doi:10.1021/acsnano.4c12212 · Cited by 42
Schrörs, B., Riesgo-Ferreiro, P., Sorn, P., Gudimella, R., Bukur, T., Rösler, T., Löwer, M., & Şahin, U. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249254 · Cited by 42
Matsushima, S., Ajiro, M., Iida, K., Chamoto, K., Honjo, T., & Hagiwara, M. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn6056 · Cited by 42
Simbulan, A. M., Banico, E. C., Sira, E. M. J. S., Odchimar, N. M. O., & Orosco, F. L. (2024) · Scientific Reports · doi:10.1038/s41598-023-51005-3 · Cited by 42
Deng, Y., Xia, L. P., Zhang, J., Deng, S., Wang, M., Wei, S., Li, K., Lai, H., Yang, Y., Bai, Y., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101489 · Cited by 41
Epitope-anchored contrastive transfer learning for paired CD8+ T cell receptor–antigen recognition
Zhang, Y., Wang, Z., Jiang, Y., Littler, D. R., Gerstein, M., Purcell, A. W., Rossjohn, J., Ou, H., & Song, J. (2024) · Nature Machine Intelligence · doi:10.1038/s42256-024-00913-8 · Cited by 42
Potter, R. A., Moeller, I. H., Khan, S. Z., Haegel, H., Hollenstein, A., Steiner, G., Wandel, C., Murphy, A. P., Asher, D. R., Palatinsky, E. A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-024-84077-w · Cited by 41
Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
Verdon, D. J., & Jenkins, M. R. (2021) · Cancers · doi:10.3390/cancers13164245 · Cited by 42
IEAtlas: an atlas of HLA-presented immune epitopes derived from non-coding regions
Cai, Y., Lv, D., Li, D., Yin, J., Ma, Y., Luo, Y. H., Fu, L., Ding, N., Li, Y., Pan, Z., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac776 · Cited by 41
Arg-tRNA synthetase links inflammatory metabolism to RNA splicing and nuclear trafficking via SRRM2
Cui, H., Diedrich, J. K., Wu, D. C., Lim, J. J., Nottingham, R. M., Moresco, J. J., Yates, J. R., Blencowe, B. J., Lambowitz, A. M., & SCHIMMEL, P. R. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01118-8 · Cited by 41
Thummalapalli, R., Ricciuti, B., Bandlamudi, C., Muldoon, D. M., Rizvi, H. A., Elkrief, A., Luo, J., Alessi, J. V., Pecci, F., Lamberti, G., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1207 · Cited by 40
Challenges and solutions for therapeutic TCR ‐based agents
Malviya, M., Aretz, Z. E. H., Molvi, Z., Lee, J., Pierre, S. A., Wallisch, P., Dao, T., & Scheinberg, D. A. (2023) · Immunological Reviews · doi:10.1111/imr.13233 · Cited by 40
Bolívar, A. M., Düzağaç, F., Deng, N., Reyes-Uribe, L., Chang, K., Wu, W., Bowen, C. M., Taggart, M. W., Thirumurthi, S., Lynch, P. M., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.016 · Cited by 40
Advances of computational methods enhance the development of multi-epitope vaccines
Wei, Y., Qiu, T., Ai, Y., Zhang, Y., Xie, J., Zhang, D., Luo, X., Sun, X., Wang, X., & Qiu, J. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf055 · Cited by 40
Subclonal immune evasion in non-small cell lung cancer
Dijkstra, K. K., Vendramin, R., Karagianni, D., Witsen, M., Gálvez‐Cancino, F., Hill, M. S., Foster, K. A., Barbè, V., Angelova, M., Hynds, R. E., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.06.012 · Cited by 40
Pyasi, S., Sharma, V., Dipti, K., Jonniya, N. A., & Nayak, D. (2021) · Vaccines · doi:10.3390/vaccines9080925 · Cited by 40
Differential T cell immune responses to deamidated adeno-associated virus vector
Bing, S. J., Justesen, S. F. L., Wu, W. W., Sajib, A. M., Warrington, S., Baer, A., Thorgrimsen, S., Shen, R., & Mazor, R. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.01.005 · Cited by 40
Lu, M., Xu, L., Jian, X., Tan, X., Zhao, J., Liu, Z., Zhang, Y., Liu, C., Chen, L., Lin, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.855976 · Cited by 40
Uchihara, Y., Permata, T. B. M., Sato, H., Kawabata‐Iwakawa, R., Katada, S., Gu, W., Kakoti, S., Yamauchi, M., Kato, R., Gondhowiardjo, S. A., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.04.030 · Cited by 40
Pyke, R. M., Mellacheruvu, D., Dea, S., Abbott, C. W., Zhang, S. V., Phillips, N. A., Harris, J., Bartha, G. T., Desai, S., McClory, R., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100506 · Cited by 39
Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS)
Yin, Z., Li, M., Niu, C., Yu, M., Xie, X., Haimiti, G., Guo, W., Shi, J., He, Y., Ding, J., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286358 · Cited by 39
MHCII-peptide presentation: an assessment of the state-of-the-art prediction methods
Yang, Y., Wei, Z., Cia, G., Song, X., Pucci, F., Rooman, M. J., Xue, F., & Hou, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1293706 · Cited by 39
Thrift, W. J., Perera, J. F., Cohen, S., Lounsbury, N., Gurung, H. R., Rose, C. M., Chen, J., Jhunjhunwala, S., & Liu, K. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae123 · Cited by 39
Mørk, S. K., Skadborg, S. K., Albieri, B., Draghi, A., Bol, K. F., Kadivar, M., Westergaard, M. C. W., Granhøj, J. S., Borch, A., Viborg, N., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-008817 · Cited by 39
Predicting T cell receptor functionality against mutant epitopes
Drost, F., Dorigatti, E., Straub, A., Hilgendorf, P., Wagner, K. I., Heyer, K., Montes, M. L., Bischl, B., Busch, D. H., Schober, K., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100634 · Cited by 39
ImmuneApp for HLA-I epitope prediction and immunopeptidome analysis
Xu, H., Hu, R., Dong, X., Kuang, L., Zhang, W., Tu, C., Li, Z., & Zhao, Z. (2024) · Nature Communications · doi:10.1038/s41467-024-53296-0 · Cited by 40
Zhao, Y., Yu, J., Su, Y., Shu, Y., Ma, E., Wang, J., Jiang, S., Wei, C., Li, D., Huang, Z., et al. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-025-01002-0 · Cited by 39
Shi, Z., Zhao, Q., Lv, B., Qu, X., Han, X., Wang, H., Qiu, J., & Hua, K. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.399 · Cited by 39
The role of neoantigens in tumor immunotherapy
Shang, S., Zhao, Y., Qian, K., Qin, Y., Zhang, X., Li, T., Shan, L., Wei, M., Xi, J., & Tang, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113118 · Cited by 39
Becerra‐Artiles, A., Calvo‐Calle, J. M., Co, M. D. T., Nanaware, P. P., Cruz, J., Weaver, G. C., Lu, L., Forconi, C. S., Finberg, R. W., Moormann, A. M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110952 · Cited by 39
Accurate TCR-pMHC interaction prediction using a BERT-based transfer learning method
Zhang, J., Ma, W., & Yao, H. J. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad436 · Cited by 38
Translation dysregulation in cancer as a source for targetable antigens
Weller, C., Bartok, O., McGinnis, C. S., Palashati, H., Chang, T., Malko, D. B., Shmueli, M. D., Nagao, A., Hayoun, D., Murayama, A., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.003 · Cited by 38
Self-citationOlsson, N., Heberling, M. L., Zhang, L., Jhunjhunwala, S., Phung, Q. T., Lin, S., Anania, V. G., Lill, J. R., & Elias, J. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.662443 · Cited by 38
Saba, A. A., Adiba, M., Saha, P., Hosen, M. I., Chakraborty, S., & Nabi, A. N. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104703 · Cited by 38
Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma
Dong, C., Cesarano, A., Bombaci, G., Reiter, J. L., Yu, C. Y., Wang, Y., Jiang, Z., Zaid, M. I. A., Huang, K., Lu, X., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02005-y · Cited by 38
Ras-Carmona, A., Pelaez-Prestel, H. F., Lafuente, E. M., & Reche, P. A. (2021) · Cells · doi:10.3390/cells10102744 · Cited by 38
Müller, T. R., Sekine, T., Trubach, D., Niessl, J., Chen, P., Bergman, P., Blennow, O., Hansson, L., Mielke, S., Nowak, P., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg9452 · Cited by 37
Chawla, M., Orduz, A. F. C., Akthar, N., Magdaleno, J. S. L., Rattanabunyong, S., Suwattanasophon, C., Jongkon, N., Choowongkomon, K., Shaikh, A. R., Malik, T., et al. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1280273 · Cited by 37
Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions
Koşaloğlu‐Yalçın, Z., Lee, J., Greenbaum, J., Schoenberger, S. P., Miller, A. M., Kim, Y. J., Sette, A., Nielsen, M., & Peters, B. (2022) · iScience · doi:10.1016/j.isci.2022.103850 · Cited by 37
Self-citationTracking SARS-CoV-2 Mutations & Variants Through the COG-UK-Mutation Explorer
Wright, D. W., Harvey, W. T., Hughes, J., Cox, M., Peacock, T. P., Colquhoun, R., Jackson, B., Orton, R. J., Nielsen, M., Hsu, S. N., et al. (2022) · Virus Evolution · doi:10.1093/ve/veac023 · Cited by 37
Self-citationBedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma
Mohsen, M. O., Speiser, D. E., Michaux, J., Pak, H., Stevenson, B. J., Vogel, M. T., Inchakalody, V. P., de Brot, S., Dermime, S., Coukos, G., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002927 · Cited by 37
Buckley, P. R., Lee, C. H.-J., Ma, R., Woodhouse, I. B., Woo, J., Tsvetkov, V. O., Shcherbinin, D. S., Antanaviciute, A., Shugay, M., Rei, M., et al. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac141 · Cited by 40
Pathak, R. K., Lim, B., Kim, D., & Kim, J. (2022) · BMC Veterinary Research · doi:10.1186/s12917-022-03432-z · Cited by 37
Seq2Neo: A Comprehensive Pipeline for Cancer Neoantigen Immunogenicity Prediction
Diao, K., Chen, J., Wu, T., Wang, X., Wang, G., Sun, X., Zhao, X., Wu, C., Wang, J., Yao, H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911624 · Cited by 37
Boll, L. M., de Oca, S. V. M., Camarena, M. E., Castelo, R., Bellmunt, J., Perera‐Bel, J., & Albà, M. M. (2025) · Nature Communications · doi:10.1038/s41467-025-56462-0 · Cited by 36
Kim, H.-Y. (2025) · Biomolecules · doi:10.3390/biom15070935 · Cited by 36
Hamelin, D. J., Fournelle, D., Grenier, J., Schockaert, J., Kovalchik, K. A., Kubiniok, P., Mostefai, F., Duquette, J. D., Saab, F., Sirois, I., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2021.09.013 · Cited by 37
Nesterenko, P. A., McLaughlin, J., Tsai, B. L., Sojo, G. B., Cheng, D., Zhao, D. Y., Mao, Z., Bangayan, N. J., Obusan, M. B., Su, Y., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110167 · Cited by 36
Johansson, A. M., Malhotra, U., Kim, Y. G., Gomez, R., Krist, M. P., Wald, A., Koelle, D. M., & Kwok, W. W. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010203 · Cited by 36
Integrating machine learning to advance epitope mapping
Grewal, S., Hegde, N., & Yanow, S. K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1463931 · Cited by 35
Roerden, M., Castro, A., Cui, Y., Harake, N., Kim, B., Dye, J., Maiorino, L., White, F. M., Irvine, D. J., Litchfield, K., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010249 · Cited by 36
Leveraging mRNA technology for antigen based immuno-oncology therapies
Floudas, C. S., Sarkizova, S., Ceccarelli, M., & Zheng, W. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010569 · Cited by 35
Metadata
- Authors
- Reynisson, B., Alvarez, B., Paul, S., Peters, B., & Nielsen, M.
- Affiliations
- Technical University of Denmark (DK)
- National University of General San Martín (AR)
- La Jolla Institute for Immunology (US)
- Corresponding author
- Nielsen, Morten
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-14
- Volume
- 48
- Issue
- W1
- Pages
- W449-W454
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC7319546
- OpenAlex
- W3024570138
- Cited by
- 2,361
- References
- 26
- Citations by year
- 2026: 493 · 2025: 550 · 2024: 459 · 2023: 345 · 2022: 250 · 2021: 216 · 2020: 47
- FWCI
- 69.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, public-domain)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (75N93019C00001)
- EIT Health (19638)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
- Keywords
- MHC-peptide binding prediction, MHC class I, MHC class II, antigen presentation, NetMHCpan, machine learning, web server, T cell response
- MeSH terms
- Machine Learning, Histocompatibility Antigens Class II, Ligands, Peptides, Software, Histocompatibility Antigens Class I, Antigen Presentation, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.